D.B. Root & Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,910
| Closed | -$349K | – | 186 |
|
|
2024
Q2 | $349K | Sell |
5,910
-9,231
| -61% | -$545K | 0.12% | 143 |
|
|
2024
Q1 | $1.21M | Sell |
15,141
-1,856
| -11% | -$148K | 0.41% | 60 |
|
|
2023
Q4 | $1.34M | Buy |
16,997
+614
| +4% | +$48.5K | 0.49% | 51 |
|
|
2023
Q3 | $1.14M | Sell |
16,383
-20
| -0.1% | -$1.4K | 0.45% | 61 |
|
|
2023
Q2 | $1.13M | Buy |
16,403
+1,268
| +8% | +$87.7K | 0.43% | 64 |
|
|
2023
Q1 | $1.12M | Buy |
15,135
+1,607
| +12% | +$119K | 0.44% | 66 |
|
|
2022
Q4 | $1.26M | Buy |
13,528
+552
| +4% | +$51.4K | 0.53% | 46 |
|
|
2022
Q3 | $1.24M | Sell |
12,976
-208
| -2% | -$19.8K | 0.56% | 41 |
|
|
2022
Q2 | $1.22M | Buy |
13,184
+203
| +2% | +$18.8K | 0.52% | 47 |
|
|
2022
Q1 | $1.31M | Buy |
12,981
+52
| +0.4% | +$5.26K | 0.49% | 50 |
|
|
2021
Q4 | $1.33M | Sell |
12,929
-224
| -2% | -$23.1K | 0.48% | 47 |
|
|
2021
Q3 | $1.12M | Sell |
13,153
-64
| -0.5% | -$5.43K | 0.44% | 52 |
|
|
2021
Q2 | $1.1M | Sell |
13,217
-118
| -0.9% | -$9.84K | 0.41% | 56 |
|
|
2021
Q1 | $1M | Buy |
13,335
+3
| +0% | +$226 | 0.39% | 61 |
|
|
2020
Q4 | $910K | Sell |
13,332
-1,343
| -9% | -$91.7K | 0.36% | 67 |
|
|
2020
Q3 | $857K | Sell |
14,675
-77
| -0.5% | -$4.5K | 0.34% | 76 |
|
|
2020
Q2 | $958K | Sell |
14,752
-66
| -0.4% | -$4.29K | 0.42% | 62 |
|
|
2020
Q1 | $879K | Buy |
14,818
+954
| +7% | +$56.6K | 0.44% | 62 |
|
|
2019
Q4 | $1.03M | Sell |
13,864
-114
| -0.8% | -$8.46K | 0.45% | 62 |
|
|
2019
Q3 | $881K | Buy |
13,978
+965
| +7% | +$60.8K | 0.41% | 71 |
|
|
2019
Q2 | $709K | Buy |
13,013
+627
| +5% | +$34.2K | 0.31% | 93 |
|
|
2019
Q1 | $668K | Buy |
12,386
+647
| +6% | +$34.9K | 0.29% | 100 |
|
|
2018
Q4 | $769K | Buy |
11,739
+910
| +8% | +$59.6K | 0.38% | 83 |
|
|
2018
Q3 | $852K | Buy |
10,829
+870
| +9% | +$68.5K | 0.38% | 85 |
|
|
2018
Q2 | $641K | Buy |
+9,959
| New | +$641K | 0.3% | 114 |
|